Marktprognose für Schnelltestkits in Süd- und Mittelamerika bis 2030 – Regionale Analyse – nach Typ (Schnelltests auf Antigene, Schnelltests auf Antikörper und andere), Produkt (rezeptfreie Schnelltestkits und professionelle Schnelltestkits), Technologie (Lateralflusstest, Festphasentest, Agglutinationstest, Immunospot-Test und auf zellulären Komponenten basierend), Anwendung (Blutzuckertests, Tests auf Infektionskrankheiten, Schwangerschaft und Fruchtbarkeit, kardiometabolische Tests und andere) und Endbenutzer (Krankenhäuser und Kliniken, häusliche Pflege, Diagnosezentren und andere)
Zunehmende Präferenz für PCR-Techniken stärkt den Markt für Schnelltestkits in Süd- und Mittelamerika
In den letzten Jahren haben sich molekulare Methoden wie die PCR zu effektiveren Diagnoseinstrumenten entwickelt, da sie bei der genauen Diagnose einer breiten Palette von Infektionskrankheiten helfen. Die meisten gängigen molekularen Tests verwenden die Reverse-Transkriptase-Polymerase-Kettenreaktion (RT-PCR). Die Technik liefert reproduzierbare Ergebnisse, die zwischen verschiedenen Laboren vergleichbar sind und daher weltweit akzeptiert werden. Die Hersteller sind an neuen PCR-Entwicklungen beteiligt.
GeneSoC beispielsweise ist ein kürzlich entwickeltes System, bei dem die PCR-Reaktionslösungen wechselseitig über zahlreiche vorgeheizte Zonen geleitet und auf einem Chip in einem extrem dünnen Strömungskanal gekapselt werden. GeneSoC ist für Multiplex-Echtzeit-PCR verfügbar und kann 3 Fluoreszenzkanäle gleichzeitig erkennen. Es gilt als hervorragende alternative Diagnosetechnologie zum Nachweis von Influenza-A- und -B-Viren, da es die Echtzeit-RT-PCR-Reaktion in ca. 16 Minuten abschließt. Darüber hinaus nimmt die Anwendung von PCR-Technologien auch in der klinischen Mikrobiologie, Virologie, Parasitologie, Biotechnologie und verwandten Bereichen zu, da dieses Tool ein einfaches, schnelles und hochspezifisches Screening ermöglicht. Daher wird erwartet, dass die wachsende Präferenz für PCR als diagnostisches und klinisches Tool dem Markt für Schnelltestkits im Prognosezeitraum lukrative Möglichkeiten bietet.
Marktübersicht für Schnelltestkits in Süd- und Mittelamerika
Laut der Weltgesundheitsorganisation (WHO) gehört Brasilien zu den 20 Ländern mit einer hohen Tuberkuloserate. Brasilien machte 33 % aller im Jahr 2020 gemeldeten Fälle aus. Im Jahr 2021 verzeichnete Brasilien 68.271 neue TB-Fälle, was einer Inzidenzrate von 32 Fällen pro 100.000 Menschen entspricht. Die TB-Inzidenz nimmt aufgrund eines Aufwärtstrends in Brasilien langsam zu. In Brasilien wird der Xpert MTB/RIF-Test – ein schneller molekularer Test auf Tuberkulose (RMT-TB) – zur Diagnose neuer Fälle von Lungen- und Kehlkopftuberkulose bei Erwachsenen und Jugendlichen verwendet.
Während der COVID-19-Pandemie in Brasilien gab das Gesundheitsministerium des Landes etwa ein Drittel der 22,9 Millionen RT-PCR-Testkits aus. Die Bundesregierung stellte 6,43 Millionen Echtzeit-PCR-Tests zum Nachweis von SARS-CoV-2 in den Bundesstaaten zur Verfügung. In Brasilien sind mehrere Akteure an der Herstellung von Schnelltestkits beteiligt. Daher werden die oben genannten Faktoren wahrscheinlich zum Wachstum des Marktes für Schnelltestkits beitragen.
Umsatz und Prognose des Marktes für Schnelltestkits in Süd- und Mittelamerika bis 2030 (Mio. USD)
Segmentierung des Marktes für Schnelltestkits in Süd- und Mittelamerika
Der Markt für Schnelltestkits in Süd- und Mittelamerika ist nach Typ, Produkt, Technologie, Anwendung, Endbenutzer und Land segmentiert. Nach Typ ist der Markt für Schnelltestkits in Süd- und Mittelamerika in schnelle Antigentests, schnelle Antikörpertests und andere unterteilt. Das Segment der schnellen Antigentests hatte 2022 den größten Marktanteil.
In Bezug auf das Produkt ist der Markt für Schnelltestkits in Süd- und Mittelamerika in rezeptfreie Schnelltestkits und professionelle Schnelltestkits unterteilt. Das Segment der rezeptfreien Schnelltestkits hatte 2022 einen größeren Marktanteil.
Nach Technologie ist der Markt für Schnelltestkits in Süd- und Mittelamerika in Lateral-Flow-Assay, Festphasen-, Agglutinations-, Immunospot-Assay und zellkomponentenbasierte Tests segmentiert. Das Segment Lateral-Flow-Assays hatte 2022 den größten Marktanteil.
Basierend auf der Anwendung ist der Markt für Schnelltestkits in Süd- und Mittelamerika in Blutzuckertests, Tests auf Infektionskrankheiten, Schwangerschaft und Fruchtbarkeit, kardiometabolische Tests und andere unterteilt. Das Segment Blutzuckertests hatte 2022 den größten Marktanteil.
In Bezug auf den Endverbraucher ist der Markt für Schnelltestkits in Süd- und Mittelamerika in Krankenhäuser und Kliniken, häusliche Pflege, Diagnosezentren und andere unterteilt. Das Segment Krankenhäuser und Kliniken hatte 2022 den größten Marktanteil.
Basierend auf dem Land ist der Markt für Schnelltestkits in Süd- und Mittelamerika in Brasilien, Argentinien und den Rest von Süd- und Mittelamerika unterteilt. Brasilien dominierte 2022 den Marktanteil für Schnelltestkits in Süd- und Mittelamerika.
F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, Guangzhou Wondfo Biotech Co Ltd, Abbott Laboratoriess, Trinity Biotech Plc, Premier Medical Corp Pvt Ltd, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA und Beckman Coulter Inc sind einige der führenden Akteure auf dem Markt für Schnelltestkits in Süd- und Mittelamerika.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Rapid Test Kits Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Genetic and Infectious Diseases
4.1.2 Strategic Initiatives by Manufacturers
4.2 Market Restraints
4.2.1 Uncertainties Related to Accuracy of Results
4.3 Market Opportunities
4.3.1 Increasing Preference for PCR Techniques
4.4 Future Trends
4.4.1 Innovations in Rapid Antigen Tests
4.5 Impact Analysis
5. Rapid Test Kits Market - South & Central America Market Analysis
5.1 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
6. South & Central America Rapid Test Kits Market Analysis - by Type
6.1 Overview
6.2 Rapid Antigen Testing
6.2.1 Overview
6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Rapid Antibody Testing
6.3.1 Overview
6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Rapid Test Kits Market Analysis - by Product
7.1 Overview
7.2 Over-the-Counter Rapid Testing Kit
7.2.1 Overview
7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Professional Rapid Testing Kit
7.3.1 Overview
7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Rapid Test Kits Market Analysis - by Technology
8.1 Overview
8.2 Lateral Flow Assay
8.2.1 Overview
8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Solid Phase
8.3.1 Overview
8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Agglutination
8.4.1 Overview
8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Immunospot Assay
8.5.1 Overview
8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Cellular-Component Based
8.6.1 Overview
8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Rapid Test Kits Market Analysis - by Application
9.1 Overview
9.2 Blood Glucose Testing
9.2.1 Overview
9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Infectious Disease Testing
9.3.1 Overview
9.3.2 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million)
9.3.3 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Cardiometabolic Testing
9.4.1 Overview
9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Pregnancy and Fertility
9.5.1 Overview
9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Rapid Test Kits Market Analysis - by End User
10.1 Overview
10.2 Hospital and Clinics
10.2.1 Overview
10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
10.3.1 Overview
10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Home-Care
10.4.1 Overview
10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11. South & Central America Rapid Test Kits Market - Country Analysis
11.1 South & Central America
11.1.1 Overview
11.1.2 South & Central America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
11.1.2.1 Brazil
11.1.2.1.1 Overview
11.1.2.2 Brazil: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.2.2.1 Brazil: Rapid Test Kits Market Breakdown, by Type
11.1.2.2.2 Brazil: Rapid Test Kits Market Breakdown, by Product
11.1.2.2.3 Brazil: Rapid Test Kits Market Breakdown, by Technology
11.1.2.2.4 Brazil: Rapid Test Kits Market Breakdown, by Application
11.1.2.2.4.1 Brazil: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.2.2.5 Brazil: Rapid Test Kits Market Breakdown, by End User
11.1.2.3 Argentina
11.1.2.3.1 Overview
11.1.2.4 Argentina: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.2.4.1 Argentina: Rapid Test Kits Market Breakdown, by Type
11.1.2.4.2 Argentina: Rapid Test Kits Market Breakdown, by Product
11.1.2.4.3 Argentina: Rapid Test Kits Market Breakdown, by Technology
11.1.2.4.4 Argentina: Rapid Test Kits Market Breakdown, by Application
11.1.2.4.4.1 Argentina: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.2.4.5 Argentina: Rapid Test Kits Market Breakdown, by End User
11.1.2.5 Rest of South & Central America
11.1.2.5.1 Overview
11.1.2.6 Rest of South & Central America: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.2.6.1 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Type
11.1.2.6.2 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Product
11.1.2.6.3 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Technology
11.1.2.6.4 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Application
11.1.2.6.4.1 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.2.6.5 Rest of South & Central America: Rapid Test Kits Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Rapid Test Kit Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 F. Hoffmann-La Roche Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Becton Dickinson and Co
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 ARKRAY Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Fujirebio Europe NV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 bioMerieux SA
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Cepheid
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Meril Life Sciences Pvt Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 QIAGEN NV
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Guangzhou Wondfo Biotech Co Ltd
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Abbott Laboratories
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Trinity Biotech Plc
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Bio-Rad Laboratories Inc
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 Hologic Inc
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 DiaSorin SpA
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Premier Medical Corp Pvt Ltd
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 Beckman Coulter Inc
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
14. Appendix
14.1 About The Insight Partners
List of Tables
Table 1. Rapid Test Kits Market Segmentation
Table 2. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Brazil: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 4. Brazil: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 5. Brazil: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 6. Brazil: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 7. Brazil: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 8. Brazil: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. Argentina: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 10. Argentina: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 11. Argentina: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 12. Argentina: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 13. Argentina: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 14. Argentina: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Rest of South & Central America: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 16. Rest of South & Central America: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 17. Rest of South & Central America: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 18. Rest of South & Central America: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. Rest of South & Central America: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 20. Rest of South & Central America: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 21. Recent Inorganic Growth Strategies in the Rapid Test Kit Market
Table 22. Recent Organic Growth Strategies in the Rapid Test Kit Market
List of Figures
Figure 1. Rapid Test Kits Market Segmentation, By Country
Figure 2. Rapid Test Kits Market: Key Industry Dynamics
Figure 3. Rapid Test Kits Market: Impact Analysis of Drivers and Restraints
Figure 4. Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Rapid Test Kits Market Share (%) - by Type (2022 and 2030)
Figure 6. Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Rapid Test Kits Market Share (%) - by Product (2022 and 2030)
Figure 10. Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Rapid Test Kits Market Share (%) - by Technology (2022 and 2030)
Figure 13. Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Rapid Test Kits Market Share (%) - by Application (2022 and 2030)
Figure 19. Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Rapid Test Kits Market Share (%) - by End User (2022 and 2030)
Figure 25. Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. South & Central America: Parenteral Nutrition Market, By Key Country - Revenue (2022) (US$ Million)
Figure 30. South & Central America: Rapid Test Kits Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 31. Brazil: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 32. Argentina: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 33. Rest of South & Central America: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 34. Growth Strategies in the Rapid Test Kit Market
1. F. Hoffmann-La Roche Ltd
2. Becton Dickinson and Co
3. ARKRAY Inc
4. Fujirebio Europe NV
5. bioMerieux SA
6. Cepheid
7. Meril Life Sciences Pvt Ltd
8. QIAGEN NV
9. Guangzhou Wondfo Biotech Co Ltd
10. Abbott Laboratories
11. Trinity Biotech Plc
12. Bio-Rad Laboratories Inc
13. Hologic Inc
14. Premier Medical Corp Pvt Ltd
15. DiaSorin SpA
16. Beckman Coulter Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America rapid test kit market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America rapid test kit market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America rapid test kit market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.